Abstract
ObjectivePlatelet-to-lymphocyte ratio (PLR), known as a key systemic inflammatory parameter, has been proved to be associated with response to neoadjuvant therapy in breast cancer (BC); however, the results remain controversial....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have